ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
3369	National Human Genome Research Institute	Html	null	About the Therapeutics for Rare and Neglected Diseases Program	"The National Institutes of Health (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program is part of a congressionally funded effort to encourage and speed the development of new drugs for rare and neglected diseases. The federal budget for fiscal 2009 dedicated $24 million to establish this initiative.			CLICK HERE
15537	National Institute of Allergy and Infectious Diseases	Html	en	Flu (Influenza) Vaccine Research	NIAID flu vaccine research	risk assessment 0.247548 influenza infection 0.280409 2014-2015 flu season 0.47415 flu vaccine production 0.613927 newly emerging influenza 0.34218 research efforts 0.247925 seasonal flu vaccines 0.542694 annual seasonal flu 0.471143 Disease Control 0.250505 new flu strain 0.471191 upcoming flu season 0.477548 antigenic drift 0.307304 research program 0.246112 yearly flu vaccine 0.573896 previous flu vaccinations 0.495563 time-consuming production process 0.293358 vaccine platforms 0.325389 vaccine effectiveness 0.327853 pandemic influenza research 0.321638 multiple flu strains 0.573276 human flu viruses 0.500005 influenza surveillance 0.277497 seasonal flu viruses 0.515262 Scientists 0.218194	influenza vaccine production 0.39304 universal flu vaccine 0.691041 multiple flu subtypes 0.458878 multiple flu seasons 0.518895 basic understanding 0.248089 Influenza pandemics 0.282272 U.S. Centers 0.25193 changes 0.229679 flu vaccine 0.97962 dominant strains 0.296906 globally circulating flu 0.490336 potential pandemic strains 0.361387 immune response 0.256994 person-to-person 0.211008 flu vaccine research 0.531986 seasonal flu vaccine 0.95459 protections 0.210719 vaccine strains 0.377045 NIAID 0.29333 unexpected flu strain 0.481882 people 0.229954 flu vaccine strain 0.555725 poor match 0.24891 key focus 0.246436	CLICK HERE
15538	National Institute of Allergy and Infectious Diseases	Html	en	NIAID's Programs on Asthma in the Inner City	Recognizing that asthma severity in inner-city children is disproportionately high, NIAID has sponsored research to reduce the public health burden that asthma presents in inner-city populations. Beginning in 1991, NIAID has supported three consecutive inner-city asthma research programs, which have been successful in reducing asthma severity in children.	inner-city populations 0.579525 Morgan WJ 0.496915 cockroach allergen 0.471241 inner-city children. 0.516784 asthma severity 0.746089 inner-city adolescents 0.569622 environmental intervention study 0.506189 clinical trials 0.457073 Infectious Diseases networks 0.482159 asthma exacerbations 0.604543 asthma attacks 0.618501 Gergen PJ 0.506952 City Anti-IgE Therapy 0.499916 asthma 0.9777 Pongracic JA 0.498 Szefler SJ 0.504609 Busse WW. Management 0.518055 Asthma Control Evaluation 0.678562 asthma treatment guidelines 0.681693 Gruchalla RS 0.496061 Allergy Clin Immunol. 0.483813 Busse WW. 0.518705 asthma management 0.634222 omalizumab 0.464849 severe allergic asthma 0.661933	asthma morbidity 0.639521 ICAC investigators 0.510592 CA. Randomized trial 0.488723 guidelines-based asthma therapy 0.667931 asthma presents 0.660928 nitric oxide level 0.504737 William Busse 0.501488 follow-on clinical trial 0.490114 asthma treatment 0.724256 public health burden 0.502806 exhaled nitric oxide 0.589522 at-risk children 0.467554 inner city 0.546793 Liu AH 0.496615 Teach SJ 0.501285 clinical guidelines 0.486081 principal investigators 0.485986 Asthma counselors 0.64051 ICAC program 0.497263 inner-city asthma research 0.793594 basic research sites 0.543997 year-long study 0.459719 inner-city children 0.771731 asthma symptoms 0.641572	CLICK HERE
15545	National Institute of Allergy and Infectious Diseases	Html	en	Methicillin-Resistant Staphylococcus aureus MRSA, Antimicrobial Resistance	NIAID conducts and supports research on methicillin-resistant Staphylococcus aureus, MRSA--drug-, or antimicrobial-, resistant bacteria that has become a serious public health concern.	Allergy 0.341577 Require 0.335974 Experts 0.328592 Research > Antimicrobial 0.486656 Pathway 0.34693 methicillin-resistant staphylococcus aureus 0.971182 controllable nuisance 0.508668 HIV Vaccine 0.518468 NIAID-Supported Institutions 0.464562 Research > NIAID 0.500955 MRSA 0.488992 News 0.326356 new strains 0.473848	Universal Influenza Vaccine 0.682447 HIV/AIDS Pandemic Likely 0.665604 public health concern 0.611156 National Institute 0.496139 NIH 0.350088 allergic diseases 0.501528 severe infections 0.473944 Role 0.327169 Infectious Diseases 0.524019 decades 0.338877 hospital-acquired infection 0.507902 Durable End 0.489538	CLICK HERE
15549	National Institute of Allergy and Infectious Diseases	Html	en	Antimicrobial Drug Resistance, NIAID, NIH	NIAID supports and conducts research on many aspects of antimicrobial (drug) resistance, or antibiotic resistance, from basic research to clinical trials.	new vaccines 0.274623 infectious diseases 0.279195 antimicrobial drug treatment 0.492562 drug-resistant microbes 0.325369 antimicrobial resistance 0.928016 infectious organisms 0.275735 research portfolio 0.351624 supports research 0.304893 clinical trials 0.277383 antimicrobial drug 0.516315 NIAID laboratories 0.477113 NIAID-supported research 0.295594 clinical research 0.369869 important clinical questions 0.324644 open NIAID Requests 0.530136 NIAID Funding Opportunities 0.523623 NIAID research 0.580865 hospital-acquired infections 0.274304 Clinical research projects 0.349601 drug-resistant Staphylococcus aureus 0.333068 NIAID conducts 0.508062 faster diagnostics 0.275989 Institute’s research 0.298397 resistant diseases NIAID 0.561618	NIAID researchers 0.477146 novel prevention strategies 0.319996 antimicrobial drugs 0.69881 NIAID research efforts 0.571105 new antimicrobial therapeutics 0.459619 public health threats 0.318497 NIAID’s Antibacterial 0.53608 Antibacterial Research Program 0.46669 basic research discoveries 0.353884 NIAID plans 0.499656 public health 0.32965 clinical research activities 0.348221 antibacterial resistance 0.553694 NIAID 0.879483 latest scientific advances 0.326471 biomedical research 0.290746 microbes 0.351855 public health efforts 0.319101 Research Program accomplishments 0.354154 antimicrobial resistance research 0.617628 NIAID efforts 0.478833 Antibacterial Resistance Leadership 0.484882 basic research 0.461234 drug resistant diseases 0.437539	CLICK HERE
15550	National Institute of Allergy and Infectious Diseases	Html	en	Intramural NIAID Research Opportunities INRO, NIH	INRO is an NIAID 4-day exploratory program that connects minority science students with training opportunities in immunology and infectious diseases.	INRO email updates 0.738453 financially disadvantaged backgrounds 0.982393 multi-disciplinary research facility 0.838981 recent hurricanes 0.496559 medical students 0.522578 research training experience 0.829391 program 0.227182	NIAID 0.411192 biomedical research 0.532386 hardship 0.209827 hotel accommodations 0.500268 application process 0.466663 difficult time 0.488892 diverse research community 0.837556	CLICK HERE
15553	National Institute of Allergy and Infectious Diseases	Html	en	Autoimmune Lymphoproliferative Syndrome (ALPS)	General and NIAID research information about Autoimmune lymphoproliferative syndrome (ALPS).	red blood cells 0.498965 Genetics Home Reference 0.386541 common type 0.27372 enlarged spleen 0.273296 treatment strategies 0.256376 clinical findings 0.247554 better understanding 0.262253 inflammatory bowel diseases 0.386467 primary immune deficiency 0.43025 normal cell lifecycle 0.380592 genetic defects 0.264434 low blood cell 0.387723 abnormal buildup 0.395762 low count 0.525489 common autoimmune diseases 0.498412 blood cells. 0.260493 research questions 0.258643 autoimmune lymphoproliferative syndrome 0.860748 systemic lupus erythematosus 0.388262 NIAID researchers 0.384049 white blood cells 0.708626 numerous autoimmune problems 0.563557 lymphoproliferative syndrome site 0.41581 related disorders 0.38884	major clinical symptoms 0.374436 NIAID PIDD site 0.506663 current management 0.256481 National Library 0.256237 increased risk 0.262725 PIDD research 0.257719 autoimmune diseases 0.588163 effective treatments 0.265251 risk factors 0.248383 white blood cell 0.447537 cell death 0.256903 genetic characteristics 0.264791 patient care 0.257891 rheumatoid arthritis 0.249292 rare genetic disorder 0.433441 ALPS 0.995498 NIAID focus 0.38608 FAS gene cause 0.410071 autoimmune destruction 0.357642 lymph nodes 0.291536 FAS gene 0.591557 genome sequencing 0.254615 debilitating symptoms 0.274164	CLICK HERE
15804	National Institute of Allergy and Infectious Diseases	Html	en	Food Allergy	NIAID supports food allergy research, which spans the spectrum from basic research in allergy and immunology to clinical trials that are testing new strategies to treat and prevent food allergy.	prevention options 0.339349 ongoing clinical trials 0.370651 lead Institute 0.347558 NIAID-funded scientists 0.33777 new strategies 0.345355 current evidence-based recommendations 0.370416 policy report 0.342135 immune responses 0.337553 children 0.321267 faster rate 0.335898 observational studies 0.345615 significant progress 0.335698 practical ways 0.34177 National Institutes 0.383015 risk factors 0.342668 Personal medical history 0.374798 NIAID-supported study 0.337131 important role 0.337607 eosinophilic esophagitis 0.3439 United States 0.385897 allergic conditions 0.339157 common allergens plays 0.380868 gut bacteria 0.371845 Drug Administration 0.341666 scientific community 0.339254	food allergies 0.381405 NIAID researchers 0.401866 allergy clinical trials 0.47886 life-threatening response 0.347529 basic studies 0.337145 early introduction 0.341065 experimental immunotherapies 0.343557 new treatments 0.33937 careful monitoring 0.340519 active clinical trials 0.373969 baked milk 0.396405 NIAID-funded study 0.336779 comprehensive food allergy 0.510173 NIAID 0.483382 food allergy 0.951641 milk allergy foods 0.4779 biomedical research 0.341796 Clinical Immunology 0.339341 National Academies 0.341431 food allergy research 0.643116 family history 0.340464 oral allergy syndrome 0.484032 food allergens 0.388332 expert panel 0.337968	CLICK HERE
15805	National Institute of Allergy and Infectious Diseases	Html	en	Food Allergy Clinical Practice Guidelines	Food allergy guidelines on diagnosis and management coordinated by NIAID for clinicians and patients and their families.	Caregivers 0.383121 peanut-containing foods 0.381686 Prevalence 0.313364 Parents 0.353814 findings 0.313013 concise clinical guidelines 0.461617 questions 0.323879 Learning 0.314489 evidence-based recommendations 0.379741 landmark 0.313963 NIAID-sponsored Expert Panel 0.672874 results 0.31354 prevention 0.373523 health care professionals 0.450648 infants 0.331007 subsequent development 0.378893 Addendum Guidelines 0.686591 diagnosis 0.393608 Instructions 0.32361 Addendum Summary 0.492585 Early About Peanut 0.470156 high risk 0.379072 food allergy reactions 0.542215 peanut allergy. 0.458057 systematic literature review 0.422767	treatment 0.328088 study 0.314463 Allergic Reaction 0.371015 United States 0.97604 Natural History 0.369617 Systematic Review 0.366735 consensus expert opinion 0.424405 complete guidelines 0.416527 LEAP 0.314988 percent 0.314983 United States offer 0.457298 peanut allergy 0.845844 Expert Panel Report 0.425189 Clinicians 0.348136 Home Feeding 0.368046 professional organizations 0.384239 federal agencies 0.384176 committee 0.329476 patient advocacy groups 0.453308 food allergy 0.865619 Complete Addendum Guidelines 0.50746 management 0.374349 NIAID-funded clinical trial 0.447015 Low Risk 0.368843	CLICK HERE
15981	National Institute of Allergy and Infectious Diseases	Video	en	Influenza: Get the (Antigenic) Drift	Have you ever wondered why you need a flu vaccination each year? The National Institute of Allergy and Infectious Diseases explains the ever-changing nature of influenza viruses.	Action MOA Animation 0.579913 Shomu 0.416725 Allergy 0.416577 SwineFlu 0.416001 Daniel Levy 0.496516 flutube100 0.416238 Osmosis 0.416074 H1N1 Swine Flu 0.627108 Unpredictable Threat 0.498722 flu vaccination 0.597572 milos velja 0.493184 World Health Organization 0.57148 1918 Flu Pandemic 0.627835 flu virus mechanism 0.693678 reverse transcriptase 0.494547 Duration 0.949875 Virus Invades 0.512664 AMAZING DOCUMENTARY 0.485888 autoplay 0.453443 HIV life cycle 0.567135 Carolyn Bertozzi 0.598025 Infectious Diseases 0.507143 Influenza H1N1 Mechanism 0.7022 VIRUS EVOLUTION 0.501245 antigenic shift 0.607123	influenza 0.762967 720p 0.423131 iBioEducation 0.42898 Influenza animation 0.642901 Influenza Pandemics Occur 0.718554 Biology 0.416713 video 0.418444 Genetic Shift 0.503494 Berkeley/HHMI 0.429072 ever-changing nature 0.51424 views 0.737316 National Institute 0.509002 Fighting flu 0.555906 Influenza infection model 0.670194 Immune Response 0.487687 David Hager 0.509045 Scientific Animations 0.498803 DOCUMENTARY TUBE 0.482643 NIAID 0.456714 Influenza Virus Infection 0.688245 Flu Attack 0.564409 influenza viruses 0.646604 Nucleus Medical Media 0.585917 Million People 0.484786	CLICK HERE